Lachnospira is a genus of Gram-positive, obligate anaerobic bacteria within the lachnospiraceae family (Firmicutes phylum). L. pectinoschiza, the type species, is a specialist pectin fermenter that produces short chain fatty acids from plant-derived polysaccharides. The genus exhibits one of the more striking context-dependent profiles in clinical microbiome research — protective and depleted in cardiovascular, renal, and endocrine conditions, yet enriched or risk-associated in colorectal cancer, ASD, and skin inflammation.
Classification and Ecology
Lachnospira belongs to the Lachnospiraceae family (Clostridium cluster XIVa), one of the largest and most functionally diverse bacterial families in the human colon. Unlike many Lachnospiraceae that broadly degrade diverse fibers, L. pectinoschiza is a pectin specialist, reflecting an ecological niche defined by plant cell wall pectin — a polysaccharide abundant in fruits, vegetables, and legumes. This dietary substrate specificity makes Lachnospira abundance a sensitive readout of plant-rich dietary intake.
SCFA Production and Fiber Fermentation
- L. pectinoschiza ferments pectin (abundant in citrus, apples, carrots, legumes) to acetate, formate, and ethanol.
- This pectin-degrading specialization links Lachnospira abundance directly to dietary fiber intake and plant-rich diets.
- As a member of the Lachnospiraceae family, it contributes to the broader SCFA-producing consortium that maintains gut barrier integrity and modulates systemic immune function.
- Produces formate as a key metabolite — a substrate that cross-feeds to methanogens and acetogens in the anaerobic fermentation network.
- Unlike butyrate-dominant Lachnospiraceae members (Roseburia, Anaerostipes, Coprococcus), Lachnospira emphasizes acetate production, which contributes to Th2 immune regulation and colonocyte substrate provisioning through different mechanisms.
Metal Dependencies
Iron dependency is documented for fermentation enzymes across the Lachnospiraceae family. Iron-sulfur cluster enzymes are required for the anaerobic ferredoxin-dependent electron transport that drives SCFA production. Iron depletion or heavy metal displacement of Fe cofactors (by cadmium, lead) would impair Lachnospira fermentation capacity — consistent with the depletion observed in conditions with metal dyshomeostasis.
CKD — Early Biomarker
The most clinically actionable finding for Lachnospira is its role as an early dysbiosis biomarker in chronic kidney disease:
- Lachnospira is the earliest-declining Lachnospiraceae genus in CKD progression, with significant reduction detectable at CKD stage 3a — before the declines in blautia, coprococcus, anaerostipes, and roseburia that become evident at stage 3b [1].
- This early decline positions Lachnospira as a potential early warning biomarker for progressive renal disease.
- Dysbiotic patterns including Lachnospira depletion persist after initiation of renal replacement therapy, indicating that the microbial disruption becomes self-sustaining once established.
- The mechanism likely involves uremic toxin accumulation disrupting the colonic anaerobic niche that Lachnospira occupies.
Protective Associations in Cardiovascular and Thyroid Disease
Cardiovascular Disease
Depleted in acute coronary syndrome (ACS) patients post-STEMI compared to healthy controls, while pathobionts like Escherichia-Shigella and acinetobacter are enriched [2]. The loss of Lachnospira alongside other SCFA producers likely contributes to reduced colonocyte barrier integrity and increased endotoxemia in ACS.
Thyroid Disease — Graves' and Plummer
MR evidence identifies Lachnospira as protective against Graves' disease and Plummer disease (toxic nodular goiter), likely through SCFA-mediated immune regulation and propionate/acetate effects on thyroid-immune axis modulation [3].
In Hashimoto's thyroiditis patients, Lachnospira and Eubacterium_ventriosum_group and Dorea are enriched at the genus level relative to Graves' patients [4] — this enrichment in HT vs. GD suggests that the direction of thyroid immune dysregulation (autoantibody type) differentially modulates Lachnospira abundance.
Endometriosis
Significantly decreased (p=0.00008) in women with endometriosis compared to healthy controls, consistent with the broader loss of SCFA-producing commensals in inflammatory gynecological conditions [5]. The loss of acetate production may contribute to reduced epithelial barrier protection and altered estrogen metabolism in the endometriosis gut environment.
Menstrual Disorders
Lachnospira shows signals in MR analysis of gut microbiota and menstrual disorders, alongside Anaerotruncus and Haemophilus, implicating SCFA depletion in menstrual cycle disruption [6].
Risk Associations — The Paradox
Paradoxically, Lachnospira shows risk associations in several conditions:
Colorectal Cancer — MR Risk
Strong Mendelian randomization-identified risk association (OR = 4.43) for CRC, mediated through inflammatory pathways [7]. This may reflect:
- Species-level heterogeneity within the genus (different species in CRC vs. protection contexts)
- A passenger enrichment effect (certain Lachnospira species proliferating in the CRC metabolic environment rather than driving it)
- Context-specific immune modulation where acetate/formate production has different effects in tumorigenic vs. normal colonic epithelium
Hidradenitis Suppurativa — Causal Risk
Causal risk factor (OR = 2.45) via MR analysis for hidradenitis suppurativa, a chronic inflammatory skin disease characterized by recurrent abscesses [8]. The skin-gut axis mechanism may involve SCFA-mediated alteration of cutaneous immune responses or microbiome-driven systemic inflammatory priming.
Autism Spectrum Disorder — Enriched in Some Cohorts
Significantly more abundant in ASD children in Chinese cohorts [9] and identified as part of the robust ASD microbiome signature in machine-learning analysis [10]. This enrichment in ASD contrasts with its depletion in cardiovascular and renal disease, suggesting context-dependent immune effects.
Schizophrenia — Causally Elevated by SCZ
In reverse MR analysis, schizophrenia causally increases Lachnospira (OR=1.05), establishing that SCZ as a disease state alters the gut microbiome to enrich this genus [11]. This is bidirectional: SCZ enriches Lachnospira as a disease consequence, separate from whatever causal effects Lachnospira may have on SCZ risk.
Context-Dependent Effects — Interpretive Framework
The dual nature of Lachnospira — depleted in cardiovascular, renal, and endocrine conditions but enriched or risk-associated in CRC, ASD, and inflammatory skin disease — reflects several overlapping factors:
- Species heterogeneity: The genus contains multiple species with distinct metabolite profiles; genus-level analysis may obscure species-specific protective vs. risk associations.
- Metabolic environment: In cardiovascular/renal disease, Lachnospira depletion is a direct consequence of SCFA niche disruption. In CRC, certain Lachnospira species may thrive in the altered metabolic environment of the tumor-adjacent colon without causing cancer.
- Immune context dependence: Acetate and formate have bidirectional immune effects depending on host Th cell balance — in immunosuppressive disease states, the same SCFA production may accelerate pathology.
What Wikipedia Doesn't Cover
Wikipedia lacks a Lachnospira species entry. This page provides: the pectin-degradation specialization linked to plant-rich diet; CKD early biomarker status as the earliest-declining Lachnospiraceae genus detectable at stage 3a; the bidirectional thyroid disease associations (protective in GD, enriched in HT); the causal CRC risk despite SCFA production (OR=4.43); and the schizophrenia reverse-MR evidence establishing SCZ as a cause of Lachnospira enrichment.
Key Sources
- [1] — earliest-declining Lachnospiraceae genus in CKD
- [7] — MR risk association in CRC (OR=4.43)
- [3] — protective in Graves' and Plummer disease
- [2] — depleted in ACS post-STEMI
Cross-References
- short chain fatty acids — pectin fermentation to acetate, formate, and ethanol
- chronic kidney disease — earliest-depleted Lachnospiraceae genus; CKD stage 3a biomarker
- cardiovascular disease — depleted in ACS; protective metabolic role
- endometriosis — significantly depleted in endometriosis patients
- colorectal cancer — paradoxical MR risk association despite SCFA production
- autism spectrum disorder — enriched in ASD; part of robust ASD microbiome signature
- graves disease — protective via MR; depleted in GD
- schizophrenia — SCZ causally increases Lachnospira abundance (reverse MR)
- faecalibacterium prausnitzii — co-member of the SCFA-producing commensal consortium
- lachnospiraceae — family-level context; shares depletion-in-disease pattern with related genera
- iron — Fe-S cluster dependency for anaerobic fermentation enzymes